UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051079
Receipt number R000058248
Scientific Title Investigation of the Relationship between Lower Urinary Tract Symptoms and General Condition of nursing home Residents
Date of disclosure of the study information 2023/05/17
Last modified on 2023/11/16 16:35:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the Relationship between Lower Urinary Tract Symptoms and General Condition of nursing home Residents

Acronym

Investigation of the Relationship between Lower Urinary Tract Symptoms and General Condition of nursing home Residents

Scientific Title

Investigation of the Relationship between Lower Urinary Tract Symptoms and General Condition of nursing home Residents

Scientific Title:Acronym

Investigation of the Relationship between Lower Urinary Tract Symptoms and General Condition of nursing home Residents

Region

Japan


Condition

Condition

Lower urinary tract symptoms

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate systemic conditions such as lower urinary tract symptoms, medications, and frailty in nursing home residents and how they affect each other.

Basic objectives2

Others

Basic objectives -Others

Effects of drugs on frailty, association between frailty and lower urinary tract symptoms

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Effects of medications being taken on lower urinary tract symptoms

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Nursing home residents

Key exclusion criteria

(1) difficulty in measuring residual urine volume by ultrasound, (2) difficulty in answering various questions, (3) significant cognitive decline to the point of being unable to follow instructions

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Yoshinaga
Middle name
Last name Okumura

Organization

University of Fukui

Division name

Department of Urology

Zip code

9101193

Address

23-3, Matsuoka shimoaizuki, Eiheiji-cho, Yoshiga-gun, Fukui

TEL

0776618174

Email

urokumura@gmail.com


Public contact

Name of contact person

1st name Yoshinaga
Middle name
Last name Okumura

Organization

University of Fukui

Division name

Department of urology

Zip code

9101193

Address

23-3, Matsuoka shimoaizuki, Eiheiji-cho, Yoshiga-gun, Fukui

TEL

0776618174

Homepage URL


Email

urokumura@gmail.com


Sponsor or person

Institute

Department of urology, university of Fukui

Institute

Department

Personal name

Yoshinaga Okumura


Funding Source

Organization

Nothing to disclosure

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Research Ethics Committee of University of Fukui

Address

23-3, Matsuoka shimoaizuki, Eiheiji-cho, Yoshiga-gun, Fukui

Tel

0776618174

Email

rinsho-rinri@ml.u-fukui.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 05 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 12 Month 17 Day

Date of IRB

2019 Year 12 Month 24 Day

Anticipated trial start date

2019 Year 12 Month 24 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry

2024 Year 06 Month 30 Day

Date trial data considered complete

2024 Year 06 Month 30 Day

Date analysis concluded

2024 Year 09 Month 30 Day


Other

Other related information

Urinary function will be assessed through a voiding diary and bladder capacity measurement using a bladder ultrasound imaging device (Lilliam). The ACB score, which evaluates the effect of anticholinergic medication on urinary function on a 3-point scale, and the JCHS, which evaluates frailty, will be used to determine how they are related to lower urinary tract symptoms.


Management information

Registered date

2023 Year 05 Month 17 Day

Last modified on

2023 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058248


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name